CoChat

A toxicity profile of osteoprotegerin in the cynomolgus monkey.

The DOI matches its Crossref record; 29 of the 30 references it cites were found in a registry or an index.

Abstract

Osteoprotegerin (OPG) is a novel secreted glycoprotein of the tumor necrosis factor (TNF) receptor superfamily that acts as an antiresorptive agent inhibiting osteoclast maturation. OPG acts by competitively inhibiting the association of the OPG ligand with the RANK receptor on osteoclasts and osteoclast precursors. This inhibition of osteoclasts can lead to excess accumulation of newly synthesized bone and cartilage in vivo. The purpose of this study was to investigate the potential toxicity of a human recombinant form of OPG in the young cynomolgus monkey. OPG was administered by intravenous (IV) or subcutaneous (SC) injection three times per week for either 4 or 13 weeks. There were no deaths during the study, no clinical signs related to treatment, no effect on body weight, appetence, or ophthalmology. No toxicologically relevant changes in routine laboratory investigations, organ weights, or gross or histopathological findings were observed. Serum ionized calcium and phosphorus were decreased at all dose levels. Evaluations were performed to monitor biochemical markers of bone resorption ( N-telopeptide [NTx], deoxypyridinoline [DPD]), bone formation (skeletal alkaline phosphatase [s ALP], osteocalcin [OC]), parathyroid hormone [PTH], and bone density of the proximal tibia and distal radius in vivo. Dose-related decreases in NTx and/or DPD were observed at each dose level, with up to a 90% decrease in NTx noted for animals treated IV or SC at 15 mg/kg. Similar decreases were observed for s ALP and OC. PTH was increased for animals treated at 5 and 15 mg/kg (IV or SC). Trabecular bone density was increased for the majority of males and females treated IV or SC at 15 mg/kg and males treated IV at 5 mg/kg. Microscopic examination of the sternebrae revealed corresponding increases in bone. Decreases in markers of bone turnover, and corresponding increases in bone density, were consistent with the pharmacological action of OPG as an osteoclast inhibitor. The no-observable-adverse-effect level (NOAEL) of OPG was 15 mg/kg.

Overview

Integrity signals

Registry

Crossref · 10.1177/109158180302200512

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 29 references

Research works printed but not linked: 2

  1. Breen, S. A., 1996, Calcified Tissue Int., 58, 449
  2. Lees, C. J., 1998, J. Clin. Endocrinol. Metab., 83, 4298

Cited by

See all 33

Metadata

Authors
Smith, B. B., Cosenza, M. E., Mancini, A., Dunstan, C., Gregson, R., Martin, S. W., Smith, S. Y., & Davis, H.
Affiliations
  • Amgen (United States) (US)
  • Clin Trials Bio Research Ltd., Montreal, Quebec, Canada
Venue
International Journal of Toxicology
Published
2003-09
Volume
22
Issue
5
Pages
403-412
ISSN
  • 1091-5818 (ISSN-L)
  • 1092-874X
OpenAlex
W2083816793
Cited by
33
References
30
Citations by year
2024: 2 · 2023: 2 · 2022: 1 · 2019: 1 · 2018: 1 · 2017: 1 · 2015: 2 · 2013: 1 · 2012: 2
FWCI
0.92
Type
journal article
Language
en
Open access
closed
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • International Journal of Toxicology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotoxicology and immune responses
  • Health Sciences › Medicine › Oncology › Bone health and treatments
Keywords
osteoprotegerin, toxicity, Macaca fascicularis, osteoclast inhibition, RANK ligand, antiresorptive agents, bone turnover markers, bone mineral density, parathyroid hormone, no-observed-adverse-effect level, dose-limiting toxicity, intravenous administration, subcutaneous administration
MeSH terms
Amino Acids, Animals, Bone Resorption, Collagen, Dose-Response Relationship, Drug, Female, Glycoproteins, Humans, Injections, Intravenous, Injections, Subcutaneous, Macaca fascicularis, Male, Parathyroid Hormone, Peptides, Radius, Recombinant Proteins, Tibia, Biomarkers, Absorptiometry, Photon, Bone Density, Osteocalcin, Receptors, Tumor Necrosis Factor, Receptors, Cytoplasmic and Nuclear, No-Observed-Adverse-Effect Level, Collagen Type I, Osteoprotegerin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A toxicity profile of osteoprotegerin in the cynomolgus monkey. https://app.cochat.ai/papers/10.1177/109158180302200512
The paper
Smith, B. B., Cosenza, M. E., Mancini, A., Dunstan, C., Gregson, R., Martin, S. W., Smith, S. Y., & Davis, H. (2003). A toxicity profile of osteoprotegerin in the cynomolgus monkey. International Journal of Toxicology. https://doi.org/10.1177/109158180302200512

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.